1887
Volume 2022 Number 1
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Benign Prostatic Hyperplasia (BPH) is one of the most frequent diseases in men. The laser treatment for BPH has challenged TURP due to advances in laser technology, a better understanding of tissue-laser interactions, and rowing clinical experience.1 The objective of this work is to evaluate the safety and efficacy of Holmium Laser Enucleation of Prostate (HoLEP) and compare it to Bipolar Transurethral resection of the prostate (TURP). This is a prospective study to evaluate the outcomes in BPH patients undergoing surgery by HoLEP and Bipolar TURP done between January 2018 to December 2019. A total of 80 Patients were enrolled, forty undergoing HoLEP and the other forty went for Bipolar TURP for BPH. All patients with symptomatic BPH and who were candidates for surgical treatment were included. Patients with previous prostate surgery, urethral surgery, history of prostate cancer, or neurogenic bladder were excluded.1,2 Baseline parameters were almost similar between both groups in terms of age (years), International Prostatic Symptom Score (IPSS), Quality of life (QOL), Q max(ml/s), Post Void Residue (PVR), and gland size(grams) [Table 1]. Operative time and resected gland weight were more in HoLEP arm (p < 0.001). Catheter time and Hospitalization period were significantly lower in the HoLEP group (p < 0.0001). Haemoglobin drop was not significant between the two groups (p = 0.148). IPSS at three months was similar in both groups (p = 0.608). Qmax improved significantly in both groups, with 18.87 in TURP and 17.87 in HoLEP with a p-value of 0.261. PVR and QOL were similar between the two groups (P = 0.914 and P = 0.781) [Table 2]. Both Bipolar TURP and HoLEP were effective in relieving bladder outlet obstruction (BOO). HoLEP has equal efficacy compared to conventional bipolar TURP, with decreased hospital stay and catheter indwelling time.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2022.qhc.31
2021-11-28
2022-05-17
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2022/1/jemtac.2022.qhc.31.html?itemId=/content/journals/10.5339/jemtac.2022.qhc.31&mimeType=html&fmt=ahah

References

  1. Barboza LED, Malafaia O, Slongo LE, Meyer F, Nassif PAN, Tabushi FI, et al. Holmium Laser enucleation of the prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP). Revista do Colégio Brasileiro de Cirurgiões. 2015 Jun; 42:(3):165–70.
    [Google Scholar]
  2. Mir I, Date J, Shivde S, Patwardhan P, Deshmukh H. Is HoLEP the only gold standard for surgical management of benign prostatic hyperplasia? Open J Urol. 2017; 07:(09):159–65.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2022.qhc.31
Loading
/content/journals/10.5339/jemtac.2022.qhc.31
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error